Neoadjuvant chemotherapy with modified FOLFOXIRI for locally advanced rectal cancer to transform effectively EMVI and MRF from positive to negative: results of a long-term single center phase 2 clinical trial

Peer Review reports

Original Submission
13 Jul 2022	Submitted	Original manuscript
Resubmission - Version 2
	Submitted	Manuscript version 2
10 Oct 2022	Reviewed	Reviewer Report
3 Mar 2023	Reviewed	Reviewer Report - Atsushi Ogura
25 Apr 2023	Author responded	Author comments - Aiping Zhou
Resubmission - Version 3
25 Apr 2023	Submitted	Manuscript version 3
4 May 2023	Author responded	Author comments - Aiping Zhou
Resubmission - Version 4
4 May 2023	Submitted	Manuscript version 4
6 May 2023	Author responded	Author comments - Aiping Zhou
Resubmission - Version 5
6 May 2023	Submitted	Manuscript version 5
29 May 2023	Reviewed	Reviewer Report - Atsushi Ogura
Resubmission - Version 6
	Submitted	Manuscript version 6
Publishing
22 Jun 2023	Editorially accepted
27 Jun 2023	Article published	10.1186/s12885-023-11103-x

Back to article page